The history of Sildenafil presents a challenging picture for shareholders. While the initial introduction generated massive profits, the lapse of its exclusive rights opened the floodgates to cheaper competitors, dramatically eroding revenue. This creates a particular dilemma for firms relying on comparable blockbuster offerings, suggesting that a

The legacy of Viagra, and its parent company copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in revenue , its exclusivity period created a deluge of knock-off medications, significantly eroding its market share . While certain firms may try to capitalize on male sexual dysfunction, the curr